Sign in

TAKEDA PHARMACEUTICAL CO LTD

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Total revenue 4,777.45 4,581.55 4,263.76 4,027.48 3,569.01 3,197.81 3,291.19 2,097.22 1,770.53 1,732.05 1,807.38 1,777.82 1,691.69 1,557.27 1,508.93 1,419.39 1,465.97 1,538.34 1,374.80 1,305.17
Cost of revenue 2,338.12 1,580.22 1,431.51 1,244.07 1,106.85 994.31 1,089.76 659.69 495.92 558.76 535.41 520.99 490.26 447.63 433.19 317.58 285.06 289.54 278.63 279.66
Gross profit 2,439.33 3,001.33 2,832.26 2,783.41 2,462.16 2,203.50 2,201.42 1,437.53 1,274.61 1,173.30 1,271.97 1,256.83 1,201.42 1,109.64 1,075.74 1,101.80 1,180.90 1,248.79 1,096.17 1,025.51
Total operating expenses + 1,866.29 2,658.75 2,618.18 2,292.90 2,001.32 1,694.24 2,101.02 1,277.17 1,032.82 1,017.43 1,141.15 1,386.09 1,062.15 987.13 810.71 734.72 760.69 942.33 673.05 567.01
Operating income 573.04 342.59 214.08 490.51 460.84 509.27 100.41 204.97 241.79 155.87 130.83 -129.25 139.27 122.51 265.03 367.08 420.21 306.47 423.12 458.50
Non-operating income (net) -297.16 -167.50 -161.28 -115.42 -158.27 -143.03 -161.16 -110.07 -24.58 -12.52 -10.29 -16.18 19.58 7.20 -12.55 4.49 -4.38 92.08 153.72 166.88
Income before tax 275.88 175.08 52.79 375.09 302.57 366.24 -60.75 94.90 217.21 143.35 120.54 -145.44 158.85 129.71 252.48 371.57 415.83 398.55 576.84 625.38
Income tax expense 72.27 66.94 -91.41 58.05 72.41 -9.94 -105.04 -14.12 30.50 27.83 37.06 -2.40 49.29 -3.88 125.21 121.33 115.67 161.35 218.77 285.84
Net income 203.33 107.93 144.07 317.02 230.06 376.01 44.24 109.13 186.89 114.94 80.17 -145.78 106.66 131.24 124.16 247.87 297.74 234.39 355.45 335.81
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08
Total revenue 1,114.65 1,213.21 1,112.80 1,106.69 1,053.40 1,144.12 1,176.04 1,207.99 1,050.87 1,111.19 1,043.09 1,058.62 956.16 1,096.55 1,002.31 972.47 873.29 901.29 844.82 949.60 770.27 836.75 788.94 801.85 771.70 859.32 811.05 849.12 717.21 499.40 430.78 449.83 400.96 488.15 433.18 448.24 416.21 465.05 416.80 434.01 414.12 489.21 457.75 446.30 437.84 488.63 440.20 411.15 404.81 458.82 417.74 410.30 368.16 402.17 388.64 398.29 381.32 425.11 345.28 357.22 338.26 367.11 359.33 354.70 338.02 372.49 376.48 378.98 335.58 395.62 410.26
Cost of revenue 570.84 552.87 380.06 384.68 382.10 416.87 394.31 386.95 387.33 379.48 343.58 321.11 309.77 335.97 305.45 292.88 308.38 281.40 275.80 241.26 253.45 253.14 249.64 238.08 248.18 279.58 271.71 300.59 289.84 138.51 110.75 120.59 110.89 142.29 121.87 120.87 134.41 147.49 141.46 135.40 132.97 145.03 136.29 121.12 134.58 139.42 128.95 118.04 130.94 131.54 120.14 115.09 111.07 120.50 112.75 103.31 128.18 145.45 80.67 78.90 82.89 84.11 77.48 73.10 70.44 74.25 69.05 71.34 68.27 70.56 72.08
Gross profit 543.81 660.35 732.74 722.01 671.30 727.25 781.73 821.04 663.54 731.71 699.51 737.50 646.38 760.58 696.86 679.58 564.91 619.89 569.02 708.34 516.83 583.61 539.29 563.77 523.52 579.74 539.34 548.53 427.38 360.89 320.03 329.24 290.07 345.86 311.30 327.37 281.80 317.56 275.33 298.61 281.16 344.18 321.46 325.17 303.26 349.21 311.26 293.11 273.87 327.28 297.60 295.21 257.09 281.68 275.90 294.98 253.15 279.65 264.62 278.32 255.37 282.99 281.85 281.60 267.58 298.25 307.43 307.64 267.30 325.06 338.18
Total operating expenses + 496.27 466.28 663.74 537.44 746.20 660.31 597.48 654.71 673.61 626.79 748.85 568.93 557.82 613.59 592.43 529.07 566.53 503.41 471.60 459.79 366.29 440.47 490.99 396.49 585.66 526.23 498.89 538.66 551.43 248.42 246.94 230.37 370.57 257.93 271.93 132.40 343.36 262.20 266.19 145.68 317.81 287.15 260.57 275.62 631.56 266.86 258.25 229.42 303.95 260.50 244.90 247.51 285.25 547.20 75.80 78.88 620.97 70.74 61.29 57.72 544.72 65.81 62.08 62.11 551.41 73.70 70.71 64.87 564.73 56.53 86.24
Operating income 47.54 194.06 69.00 184.57 -74.90 66.94 184.25 166.33 -10.07 104.91 -49.34 168.57 88.56 146.99 104.44 150.52 -1.62 116.48 97.43 248.55 150.54 143.14 48.30 167.29 -62.14 53.51 40.44 9.87 -79.45 112.46 73.09 98.87 -80.50 87.94 39.37 194.98 -61.56 55.35 9.14 152.93 -36.65 57.03 60.89 49.56 -328.31 82.36 53.01 63.69 -30.08 66.79 52.70 47.71 -28.17 -265.53 200.10 216.10 -367.82 208.92 203.33 220.60 -289.35 217.19 219.76 219.48 -283.83 224.55 236.72 242.77 -297.42 268.53 251.94
Non-operating income (net) -100.98 -57.78 -40.82 -33.94 -32.40 -40.54 -64.88 -29.73 -37.45 -43.65 -46.64 -33.12 -40.65 -39.84 -39.02 5.46 -52.43 -44.29 -35.98 -25.57 -19.66 -33.35 -53.03 -36.99 -54.63 -28.67 -42.82 -35.05 -34.03 -64.87 -6.17 -5.01 9.81 -33.04 -4.63 3.27 -3.91 -1.55 -3.80 -3.26 2.58 -4.46 -7.57 -0.84 -4.70 -7.93 0.14 -3.70 8.67 12.00 11.69 2.48 -8.09 301.17 -145.51 -140.37 337.59 -135.75 -113.02 -101.37 324.44 -106.18 -98.13 -115.65 330.40 -110.19 -119.41 -105.18 368.41 -117.23 -143.47
Income before tax -53.44 136.28 28.17 150.63 -107.30 26.41 119.37 136.60 -47.52 61.26 -95.98 135.45 47.92 107.15 65.42 155.97 -54.05 72.19 61.45 222.98 130.88 109.80 -4.73 130.29 -116.76 24.84 -2.37 -25.19 -113.48 47.60 66.92 93.86 -70.69 54.90 34.75 198.24 -65.47 53.80 5.34 149.68 -34.07 52.57 53.32 48.72 -333.00 74.43 53.15 59.99 -21.42 78.79 64.39 50.19 -36.26 35.64 54.59 75.73 -30.24 73.17 90.32 119.24 35.09 111.00 121.64 103.83 46.57 114.36 117.31 137.59 70.98 151.30 108.47
Income tax expense -28.74 30.67 39.90 26.35 -4.20 2.57 27.27 41.30 -44.53 -44.50 -48.01 45.63 16.78 -12.00 2.82 50.45 -42.67 14.37 15.45 85.25 -66.27 17.36 -8.80 47.77 -118.32 56.95 -56.29 -4.55 -58.14 9.74 18.51 15.78 -16.71 -13.12 7.07 53.25 -12.95 11.37 -19.92 49.33 -1.18 -7.81 22.76 23.29 -107.63 55.24 24.30 25.68 -16.52 22.52 20.45 20.48 -29.42 16.46 21.70 -12.62 5.68 47.43 29.49 42.62 2.62 38.90 40.83 38.99 7.54 44.11 39.68 24.35 4.89 53.73 38.50
Net income -24.77 105.51 -11.80 124.24 -103.20 23.79 92.05 95.25 -3.02 105.72 -48.03 89.40 31.13 119.13 61.74 105.01 -11.36 57.77 45.96 137.68 197.10 92.36 4.04 82.51 1.72 -32.22 53.84 -20.66 -55.31 37.77 48.43 78.24 -54.02 68.09 28.03 144.79 -50.73 41.37 24.77 99.53 -33.48 59.26 29.80 24.58 -225.52 18.31 28.04 33.40 -4.34 54.53 42.80 29.08 -7.67 19.12 32.23 87.56 -36.45 24.95 60.08 75.58 32.38 71.28 80.10 64.11 38.60 69.52 77.04 112.59 65.81 96.79 69.29
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Total cash and short-term investments + 597.63 405.59 472.89 553.70 875.00 1,002.82 653.44 725.37 375.17 376.14 560.03 713.42 851.03 305.85 460.52 219.41 883.22 758.78 3,058.71 1,799.94
Accounts receivable, net 880.15 725.25 697.61 681.69 724.38 812.71 784.92 749.12 428.79 444.78 430.57 466.83 442.66 387.02 361.87 283.59 279.70 301.45 388.25 400.66
Inventories 1,402.68 1,217.35 1,209.87 986.46 853.17 753.88 759.60 986.74 212.94 226.29 254.01 262.35 254.33 229.53 195.01 137.13 137.70 131.66 116.13 105.31
Other current assets 223.45 173.00 178.21 176.10 141.10 143.48 271.48 598.88 61.90 213.45 129.18 77.47 44.51 53.31 43.28 574.91 551.96 585.15 442.67 452.47
Total current assets 3,103.91 2,521.19 2,558.58 2,397.96 2,593.64 2,712.89 2,469.43 3,050.66 1,078.81 1,260.66 1,373.79 1,520.07 1,592.54 1,455.08 1,279.00 1,586.25 1,572.87 1,475.58 2,243.79 2,357.71
Total non-current assets + 12,416.23 11,727.15 12,550.21 11,559.79 10,584.38 10,199.40 10,351.66 10,799.74 3,027.66 3,086.38 2,450.30 2,776.12 2,976.61 2,821.15 2,544.57 1,200.15 1,250.40 1,284.60 605.49 714.79
Total assets 15,520.14 14,248.34 15,108.79 13,957.75 13,178.02 12,912.29 12,821.09 13,872.32 4,106.46 4,355.78 3,824.09 4,296.19 4,569.14 3,955.60 3,577.03 2,786.40 2,823.27 2,760.19 2,849.28 3,072.50
Total current liabilities + 2,440.07 2,506.52 2,313.10 2,481.94 2,145.73 1,773.18 2,175.90 2,510.93 737.51 1,366.09 857.21 1,016.82 802.75 613.63 751.73 436.60 428.48 472.11 428.71 442.41
Total non-current liabilities + 5,271.55 4,805.84 5,521.68 5,121.14 5,348.77 5,961.94 5,917.71 6,197.80 1,351.55 1,040.73 955.67 1,073.19 1,225.76 1,118.61 753.43 213.15 230.05 234.24 98.04 168.98
Total liabilities 7,711.62 7,312.37 7,834.79 7,603.08 7,494.50 7,735.12 8,093.61 8,708.73 2,089.05 2,406.82 1,812.88 2,090.02 2,028.51 1,732.24 1,505.16 649.75 658.53 706.35 526.75 611.39
Total stockholders' equity + 7,807.31 6,935.08 7,273.26 6,354.12 5,683.02 5,173.04 4,723.48 5,159.58 1,997.42 1,894.26 1,948.69 2,137.05 2,470.74 2,159.94 2,012.35 2,091.92 2,121.34 2,011.45 2,280.78 2,420.25
Common shares outstanding 3,206 3,211 3,161 3,140 3,154 3,147 3,132 1,934 1,573 1,572 1,576 1,573 1,581 1,579 1,579 1,579 1,579 1,618 1,697 1,740
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08
Total cash and short-term investments + 597.63 762.39 739.68 419.18 405.59 526.75 906.22 857.66 472.89 317.40 333.81 368.61 553.70 726.61 830.07 664.53 875.00 751.90 633.62 684.85 1,002.82 654.30 646.18 600.93 653.44 588.42 557.43 615.09 725.37 1,864.20 337.36 250.63 375.17 466.48 460.67 490.28 376.14 738.45 739.18 732.77 560.03 660.51 667.59 637.92 713.42 856.50 841.36 762.74 851.03 732.65 719.14 384.88 305.85 422.09 412.02 381.33 460.52 384.44 405.94 820.34 219.41 762.38 805.57 771.18 883.22 807.40 808.31 0.00 758.78 606.60 0.00
Accounts receivable, net 880.15 758.44 702.24 679.53 725.25 735.06 721.06 772.37 697.61 743.08 788.07 825.48 681.69 779.87 800.54 794.09 724.38 756.12 887.30 858.96 812.71 828.94 769.81 815.27 784.92 852.13 805.74 788.63 749.12 515.79 468.92 459.72 428.79 518.69 470.86 471.16 444.78 496.86 446.20 440.42 430.57 493.73 478.37 479.83 466.83 500.22 461.78 442.09 442.66 423.63 382.12 363.65 387.02 377.10 546.59 547.44 361.87 600.29 577.05 519.68 523.90 534.67 521.39 517.74 516.89 520.17 524.89 520.55 508.48
Inventories 1,402.68 1,408.15 1,299.49 1,240.68 1,217.35 1,246.43 1,206.43 1,276.74 1,209.87 1,169.64 1,155.87 1,083.37 986.46 927.29 953.45 927.51 853.17 811.32 783.48 779.15 753.88 739.35 743.48 759.38 759.60 801.34 840.84 902.52 986.74 223.40 233.30 221.42 212.94 225.10 234.30 234.68 226.29 222.91 237.92 242.20 254.01 268.74 275.00 277.63 262.35 282.66 277.42 267.58 254.33 251.90 238.53 237.52 229.53 224.49 208.44 203.52 195.01 209.52 241.31 139.86 137.13 135.99 135.43 135.65 137.70 138.76 135.92 131.66 127.17
Other current assets 223.45 190.03 179.22 173.74 173.00 246.05 220.31 200.77 178.21 198.71 184.33 194.55 176.10 162.18 161.56 163.38 141.10 158.56 151.96 153.50 143.48 394.01 425.67 299.19 271.48 278.43 170.43 625.92 598.88 66.68 68.36 111.78 61.90 55.71 56.17 74.70 213.45 198.04 61.00 58.14 129.18 126.73 59.27 76.10 77.47 64.41 53.09 58.95 44.51 799.75 755.28 759.88 53.31 684.67 621.31 612.34 43.28 646.96 627.25 583.25 574.91 583.89 560.06 559.35 551.96 550.72 561.80 585.15 573.82
Total current assets 3,103.91 3,118.57 2,920.62 2,513.12 2,521.19 2,754.29 3,054.01 3,107.53 2,558.58 2,428.83 2,462.07 2,472.02 2,397.96 2,595.95 2,745.62 2,549.52 2,593.64 2,477.89 2,456.35 2,476.46 2,712.89 2,616.60 2,585.14 2,474.76 2,469.43 2,520.33 2,374.44 2,932.16 3,050.66 2,670.07 1,107.94 1,043.55 1,078.81 1,265.98 1,222.00 1,270.82 1,260.66 1,656.26 1,484.30 1,473.53 1,373.79 1,549.71 1,480.22 1,471.48 1,520.07 1,703.79 1,633.65 1,531.36 1,592.54 1,784.30 1,712.95 1,382.29 1,455.08 1,331.25 1,241.77 1,197.19 1,279.00 1,240.92 1,274.50 1,543.46 1,586.25 1,482.26 1,501.06 1,466.18 1,572.87 1,496.89 1,506.03 1,475.58 1,307.59
Total non-current assets + 12,416.23 12,300.73 11,549.68 11,491.42 11,727.15 12,352.56 11,518.99 13,120.15 12,550.21 11,794.12 12,409.82 12,320.72 11,559.79 10,908.76 11,843.23 11,515.91 10,584.38 10,220.63 10,103.92 10,180.78 10,199.40 9,669.54 9,829.61 10,139.09 10,351.66 10,511.17 10,505.70 10,618.27 10,799.74 3,097.15 3,166.90 3,116.03 3,027.66 3,144.58 3,153.96 3,075.11 3,086.38 2,485.77 2,317.52 2,343.48 2,450.30 2,640.17 2,733.61 2,849.37 2,776.12 2,949.58 2,938.16 2,905.97 2,976.61 2,641.49 2,540.27 2,551.42 2,821.15 2,452.48 2,240.40 2,270.76 2,544.57 2,180.46 2,224.78 1,170.11 1,200.15 1,197.81 1,207.61 1,218.17 1,250.40 1,256.43 1,233.90 1,284.60 1,247.06
Total assets 15,520.14 15,419.29 14,470.30 14,004.54 14,248.34 15,106.84 14,573.00 16,227.68 15,108.79 14,222.95 14,871.89 14,792.74 13,957.75 13,504.71 14,588.85 14,065.43 13,178.02 12,698.52 12,560.27 12,657.23 12,912.29 12,286.14 12,414.75 12,613.85 12,821.09 13,031.49 12,880.14 13,550.42 13,872.32 5,767.22 4,274.84 4,159.58 4,106.46 4,410.56 4,375.96 4,345.92 4,355.78 4,142.03 3,801.82 3,817.01 3,824.09 4,189.88 4,213.83 4,320.85 4,296.19 4,653.37 4,571.81 4,437.33 4,569.14 4,425.79 4,253.22 3,933.71 3,955.60 3,783.73 3,482.16 3,467.95 3,577.03 3,421.38 3,499.28 2,713.57 2,786.40 2,680.07 2,708.67 2,684.35 2,823.27 2,753.32 2,739.93 2,760.19 2,760.19 2,554.65 2,554.65
Total current liabilities + 2,440.07 2,611.96 2,139.66 2,169.59 2,506.52 2,097.96 2,387.24 2,465.20 2,313.10 2,282.17 2,367.62 2,501.74 2,481.94 2,236.81 2,391.72 2,166.94 2,145.73 1,809.25 1,918.75 1,706.78 1,773.18 1,804.96 1,709.66 2,031.54 2,175.90 2,127.37 1,634.63 2,006.62 2,510.93 871.71 844.19 733.44 737.51 878.17 838.77 939.62 1,366.09 957.95 808.84 822.76 857.21 1,011.25 985.98 1,010.95 1,016.82 837.92 779.16 740.64 802.75 581.08 546.99 543.62 613.63 572.79 488.28 726.44 751.73 1,027.03 1,017.20 389.44 436.60 375.07 375.45 368.00 428.48 426.45 429.92 472.11 409.77
Total non-current liabilities + 5,271.55 5,158.02 5,198.96 4,968.77 4,805.84 5,589.69 5,264.17 5,963.25 5,521.68 5,198.17 5,433.25 5,369.33 5,121.14 5,091.40 5,483.64 5,581.10 5,348.77 5,557.44 5,317.16 5,711.81 5,961.94 5,841.75 6,038.59 5,891.54 5,917.71 6,027.91 6,375.82 6,669.35 6,197.80 2,852.94 1,258.49 1,359.56 1,351.55 1,398.31 1,431.49 1,369.52 1,040.73 1,139.68 1,113.94 1,124.97 955.67 1,016.26 1,045.54 1,078.28 1,073.19 1,242.59 1,261.71 1,242.69 1,225.76 1,391.46 1,359.06 1,113.58 1,118.61 1,088.52 1,022.68 791.32 753.43 419.48 437.03 207.72 213.15 212.47 219.73 231.37 230.05 220.13 221.19 234.24 226.05
Total liabilities 7,711.62 7,769.98 7,338.61 7,138.36 7,312.37 7,687.65 7,651.40 8,428.45 7,834.79 7,480.34 7,800.86 7,871.07 7,603.08 7,328.21 7,875.36 7,748.04 7,494.50 7,366.70 7,235.91 7,418.59 7,735.12 7,646.71 7,748.25 7,923.09 8,093.61 8,155.28 8,010.46 8,675.97 8,708.73 3,724.65 2,102.68 2,093.00 2,089.05 2,276.48 2,270.26 2,309.14 2,406.82 2,097.62 1,922.77 1,947.73 1,812.88 2,027.51 2,031.52 2,089.23 2,090.02 2,080.51 2,040.88 1,983.33 2,028.51 1,972.54 1,906.05 1,657.20 1,732.24 1,661.31 1,510.97 1,517.75 1,505.16 1,446.50 1,454.23 597.16 649.75 587.54 595.18 599.37 658.53 646.57 651.11 706.35 635.82
Total stockholders' equity + 7,807.31 7,648.16 7,130.70 6,865.26 6,935.08 7,418.27 6,920.75 7,798.42 7,273.26 6,741.93 7,070.35 6,921.05 6,354.12 6,175.98 6,712.93 6,316.83 5,683.02 5,331.33 5,323.94 5,238.26 5,173.04 4,635.35 4,662.40 4,686.76 4,723.48 4,872.07 4,865.71 4,870.37 5,159.58 2,038.68 2,168.36 2,043.50 1,997.42 2,113.89 2,085.73 2,014.57 1,894.26 1,981.58 1,819.16 1,808.68 1,948.69 2,098.86 2,119.44 2,165.24 2,137.05 2,503.48 2,463.88 2,388.58 2,470.74 2,382.90 2,282.37 2,212.07 2,159.94 2,062.16 1,912.73 1,891.61 2,012.35 1,917.17 1,987.71 2,071.31 2,091.92 2,048.16 2,068.81 2,040.80 2,121.34 2,063.66 2,045.72 2,011.45 1,876.91
Common shares outstanding 3,125 3,205 3,155 3,176 3,163 3,170 3,220 3,178 3,137 3,170 3,131 3,130 3,228 3,141 3,127 3,109 3,152 3,150 3,161 3,109 3,147 3,151 3,146 3,132 3,115 3,115 3,124 3,122 3,137 1,577 1,575 1,573 1,563 1,573 1,572 1,570 1,562 1,569 1,568 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Operating cash flow + 995.32 1,057.18 716.34 977.16 1,123.11 1,010.93 669.75 328.48 377.85 261.36 25.49 182.52 148.34 307.71 336.57 326.94 381.17 326.27 292.50 209.28
Cash flow from investing + -411.19 -367.06 -463.86 -607.10 -198.13 393.53 292.12 -2,835.70 -93.34 -655.69 -71.21 91.35 -158.61 -111.38 -1,093.96 -99.26 -117.52 -767.26 101.75 116.39
Cash flow from financing + -398.08 -751.43 -354.42 -709.15 -1,070.27 -1,088.35 -1,005.21 2,946.24 -326.23 289.90 -124.84 -301.00 101.44 -150.56 393.79 -146.54 -148.05 -425.84 -262.08 -315.94
Change in cash 186.05 -61.30 -101.93 -339.09 -145.29 316.11 -43.34 439.02 -41.71 -104.43 -170.56 -27.13 91.17 45.77 -363.61 81.14 115.60 -866.82 132.16 9.73
Change in exchange rate 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08
Operating cash flow + 19.66 360.04 378.23 215.42 222.16 383.76 280.96 170.30 278.59 146.45 198.91 92.40 293.69 378.23 220.99 84.24 375.58 347.51 233.15 166.86 400.96 217.96 246.15 145.86 185.44 143.23 220.30 120.79 117.48 93.16 77.36 40.47 125.75 85.08 92.47 74.56 124.46 25.13 61.00 50.77 -145.08 75.60 76.33 18.64 32.98 64.88 72.62 12.04 105.45 49.99 82.26 -89.37 118.68 59.20 110.16 38.90 112.39 79.34 112.93 76.51 144.46 52.66
Cash flow from investing + -58.42 -247.98 -48.13 -33.19 -19.68 -115.56 -75.13 -156.69 -61.48 -75.27 -327.11 -266.53 -607.10 -168.61 -27.21 -94.71 -25.64 -69.14 -32.90 -70.45 293.33 71.98 27.56 0.66 36.25 -74.54 372.02 -41.60 -1,221.66 -1,611.89 14.95 -17.09 -107.52 -9.01 -76.14 99.33 -615.65 -28.97 -5.45 -5.61 28.06 -58.35 -20.56 -20.36 -12.09 77.96 -4.03 29.50 -15.29 -131.99 4.80 -16.13 -5.79 -30.88 -41.39 -21.20 -57.66 -20.81 -16.61 -22.45 6.27 9.17
Cash flow from financing + -31.72 -169.51 -11.98 -214.90 -301.79 -655.97 -110.05 316.38 -58.22 -97.76 -140.66 -57.78 -6.60 -434.96 -51.88 -215.72 -243.80 -168.06 -247.37 -411.04 -370.07 -300.07 -225.45 -192.77 -143.93 -49.61 -633.97 -177.70 1,534.26 1,509.15 -15.01 -82.16 -149.96 -68.13 -20.30 -87.83 258.45 -66.64 -14.35 112.44 38.03 -64.57 -11.72 -86.57 -131.83 -63.05 -26.86 -79.26 -7.90 -66.75 240.03 -63.93 -9.65 -63.83 -9.34 -63.73 -11.12 -62.87 -8.81 -65.25 -7.89 -187.01
Change in cash -70.49 -57.45 318.11 -32.67 -99.31 -387.77 95.79 329.99 158.88 -26.58 -268.86 -231.91 -320.01 -225.34 141.91 -226.19 106.15 110.31 -47.12 -314.63 324.22 -10.14 48.27 -46.24 77.75 19.08 -41.66 -98.51 430.08 -9.58 77.30 -58.78 -131.74 7.93 -3.98 86.07 -232.74 -70.48 41.20 157.59 -78.99 -47.33 44.04 -88.28 -110.94 79.79 41.73 -37.72 82.26 -148.75 327.08 -169.43 0.00 0.00 0.00 103.24 -35.51 59.43 -46.03 43.61 -4.34 87.52 -11.19 142.84 -125.18
Change in exchange rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Ebit

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Income Tax Expense

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Income Before Tax

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Depreciation And Amortization

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Interest Expense

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Operating Expenses

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Research And Development

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Operating Income

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Costof Goods And Services Sold

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Cost Of Revenue

1Y 2Y 5Y Max
about 2 months ago